Author:
Avgerinos Efthymios D.,Liapis Christos D.
Reference71 articles.
1. Goldberg AC. Section 8: Endocrine and metabolic disorders, Chapter 100: Lipid disorders. In: Porter RS, Kaplan JL, editors. The Merck manual of diagnosis and therapy. 19th ed. Whitehouse Station, NJ: Merck Sharp & Dohme Corp; 2011.
2. Ridker P, Libby P. Chapter 44: Risk markers for atherothrombotic disease. Genest J, Libby P. Chapter 47: Lipoprotein disorders and cardiovascular disease. In: Bonow RO, Mann D, Zipes D, Libby P, editors. Braunwald’s heart disease: a textbook of cardiovascular medicine. 9th ed. Philadelphia: Saunders; 2012.
3. Liapis CD. Chapter 25: Atherosclerosis risk factor treatment – general considerations. Walcott R, Howard J. Chapter 28: Atherosclerotic risk factors – hyperlipidemia. In: Cronenwett JL, Johnston W, editors. Rutherford’s vascular surgery. 7th ed. Philadelphia: W.B. Saunders; 2010.
4. Lamon BD, Haijar DP. Inflammation at the molecular interface of atherogenesis: an anthropological journey. Am J Pathol. 2008;173:1253–64.
5. Napoli C, De Nigris F, Palinski W. Multiple role of reactive oxygen species in the arterial wall. J Cell Biochem. 2001;82:674–82.